logo Menu

Offre de poste CDD Novembre 2021

Date:
Published 2021-09-09

Nous recrutons!!! Antineo-Profil-Assistant2021

Recent Posts
  • Meet us at the AFSSI Connexions

    2022-07-04
  • Press Release!

    2022-04-26
  • AACR Meeting – New Orleans April 2022

    2022-03-21
  • New Job Offer – February 2022

    2022-02-08
  • Offre de poste CDD Novembre 2021

    2021-09-09
logo

ANTINEO
Faculté de Médecine Rockefeller
8, av Rockefeller
69008 LYON
FRANCE

Tel. +33 426 688 201

contact@antineo.fr

Leave your message




    Preclinical services in oncology in vitro preclinical services Preclinical development of immunotherapies Preclinical development in vitro end point studies In vitro cytotoxicity In vitro synergy assays Cell cycle, proliferation, apoptosis Multiple colour flow cytometry Immunology and Immuno-Oncology Preclinical tumour models Resistant preclinical tumor models Preclinical Development in vitro continuous-monitoring studies xCELLigence IncuCyte Sample Characterisation Multiple colour flow cytometry Molecular Biology High throughput sequencing ex vivo preclinical services in vivo preclinical services Preclinical non-reglementary toxicity Preclinical non-reglementary pharmacokinetics Preclinical tumour models Resistant preclinical tumour models Preclinical in vivo efficacy studies Tumour and organ sampling Preclinical development of immunotherapies Immunology and Immuno-oncology Antibody dependant mechanisms in vivo ADCC assay in vivo CDC assay in vivo efficacy study for bispecific antibodies Preclinical tumour models Cell-Derived Xenografts Liquid tumours preclinical xenograft models Solid tumours preclinical xenograft models Syngeneic mice tumour models Solid tumours preclinical syngeneic models Liquid tumours preclinical syngeneic models Original preclinical resistant tumour models Patient-Derived Xenografts About Us Antineo Our Team Our scientific commitee Mission and Vision Our strengths Facilities and ressources Scientific and medical environment Equipment Network Contact News

    More

    • T cell activation

    Legals & Credits

    • Credits
    • Legals
    • About Us
      • Antineo
      • Our Team
      • Our scientific commitee
      • Mission and Vision
    • Preclinical services in oncology
      • in vitro preclinical services
        • Preclinical development of immunotherapies
        • Preclinical development in vitro end point studies
          • In vitro cytotoxicity
          • In vitro synergy assays
          • Cell cycle, proliferation, apoptosis
          • Multiple colour flow cytometry
          • Immunology and Immuno-Oncology
        • Preclinical Development in vitro continuous-monitoring studies
          • xCELLigence
          • IncuCyte
        • Preclinical tumour models
        • Original preclinical resistant tumour models
        • Sample Characterisation
          • Multiple colour flow cytometry
          • Molecular Biology
          • High throughput sequencing
      • ex vivo preclinical services
      • in vivo preclinical services
        • Preclinical non-reglementary toxicity
        • Preclinical non-reglementary pharmacokinetics
        • Preclinical tumour models
        • Resistant preclinical tumour models
        • Preclinical in vivo efficacy studies
        • Tumour and organ sampling
      • Preclinical development of immunotherapies
        • Immunology and Immuno-oncology
        • Antibody dependant mechanisms
        • in vivo ADCC assay
        • in vivo CDC assay
        • in vivo efficacy study for bispecific antibodies
    • Preclinical tumour models
      • Cell-Derived Xenografts
        • Solid tumours preclinical xenograft models
        • Liquid tumours preclinical xenograft models
      • Syngeneic mice tumour models
        • Liquid tumours preclinical syngeneic models
        • Solid tumours preclinical syngeneic models
      • Original preclinical resistant tumour models
      • Patient-Derived Xenografts
    • Our strengths
      • Facilities and ressources
      • Scientific and medical environment
      • Equipment
      • Network
      • Partners
    • Contact
    • News
    • Publications